Patent · US Active

Method of diagnosing and treating cancer using B-catenin splice variants

US8110352B2 · kind B2 · utility

1Cited by

0References

7Claims

0Family size

Assignee

The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Mark Roth · Appleton, US
Konrad Huppi · Reston, US

Key dates

Filing date	Feb 10, 2006
Grant date	Feb 7, 2012
Priority date	—
Expiry date	Jul 19, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/136
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to method of diagnosing and treating cancer, in particular β-catenin related cancers. The invention further relates to methods of identifying CTNNB1 related cancer CTNNB1 therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.